- Cybin to Participate in the Oppenheimer 33rd Annual Healthcare Conference
- Cybin and The Chopra Foundation to Participate in Featured Session at Upcoming 2023 South by Southwest® Conference
- Cybin Announces Positive Data from its CYB003 Phase 1/2a Trial and Provides Update on its CYB004 Development Program
- Cybin Announces Streamlined Clinical Alignment
- Cybin Inc. Reports Third Quarter Financial Results and Recent Business Highlights
- Cybin Announces Approval of First-in-Human Dosing of its Proprietary DMT Molecule CYB004
- Cybin to Host Virtual R&D Day on February 28, 2023
- Cybin Announces Promising Results from Sponsored Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain
- Cybin Selects Generalized Anxiety Disorder as Target Indication for Deuterated DMT Molecule CYB004
- Cybin Outlines Upcoming Priorities and Milestones for its Clinical Development Programs
Cybin Inc (R7E1:STU) closed at 0.3299, 48.14% above the 52 week low of 0.2227 set on Dec 22, 2022.
0.2227Dec 22 20221.10Aug 31 2022
Short selling activityProvided by S&P Global Market Intelligence
|Market cap||95.57m CAD|
|EPS (TTM)||-0.2904 |
Data delayed at least 15 minutes, as of Mar 21 2023.